Aug 7 |
Peering Into Dermata Therapeutics's Recent Short Interest
|
Jul 24 |
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
|
Jul 17 |
Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne
|
May 17 |
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules
|
May 17 |
Dermata Therapeutics GAAP EPS of -$0.47 beats by $5.83
|
May 15 |
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
Apr 2 |
Presenting on the Emerging Growth Conference 69 Day 1 on April 3 Register Now
|